306 related articles for article (PubMed ID: 25875873)
1. Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.
Tse-Dinh YC
Future Med Chem; 2015; 7(4):459-71. PubMed ID: 25875873
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors.
Yu X; Zhang M; Annamalai T; Bansod P; Narula G; Tse-Dinh YC; Sun D
Eur J Med Chem; 2017 Jan; 125():515-527. PubMed ID: 27689733
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel bacterial topoisomerase I inhibitors by use of in silico docking and in vitro assays.
Sandhaus S; Chapagain PP; Tse-Dinh YC
Sci Rep; 2018 Jan; 8(1):1437. PubMed ID: 29362471
[TBL] [Abstract][Full Text] [Related]
4. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
Tse-Dinh YC
Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
[TBL] [Abstract][Full Text] [Related]
5. Targeting bacterial topoisomerases: how to counter mechanisms of resistance.
Tse-Dinh YC
Future Med Chem; 2016 Jun; 8(10):1085-100. PubMed ID: 27285067
[TBL] [Abstract][Full Text] [Related]
6. DNA Topoisomerases as Targets for Antibacterial Agents.
Hiasa H
Methods Mol Biol; 2018; 1703():47-62. PubMed ID: 29177732
[TBL] [Abstract][Full Text] [Related]
7. Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.
Sandhaus S; Annamalai T; Welmaker G; Houghten RA; Paz C; Garcia PK; Andres A; Narula G; Rodrigues Felix C; Geden S; Netherton M; Gupta R; Rohde KH; Giulianotti MA; Tse-Dinh YC
Antimicrob Agents Chemother; 2016 Jul; 60(7):4028-36. PubMed ID: 27114277
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase as target for antibacterial and anticancer drug discovery.
Kathiravan MK; Khilare MM; Nikoomanesh K; Chothe AS; Jain KS
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):419-35. PubMed ID: 22380774
[TBL] [Abstract][Full Text] [Related]
9. Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development.
Tiwari PB; Chapagain PP; Seddek A; Annamalai T; Üren A; Tse-Dinh YC
ChemMedChem; 2020 Apr; 15(7):623-631. PubMed ID: 32043806
[TBL] [Abstract][Full Text] [Related]
10. A Fluorescence-Based Assay for Identification of Bacterial Topoisomerase I Poisons.
Annamalai T; Cheng B; Keswani N; Tse-Dinh YC
Methods Mol Biol; 2018; 1703():259-268. PubMed ID: 29177747
[TBL] [Abstract][Full Text] [Related]
11. DNA Topoisomerases.
Bush NG; Evans-Roberts K; Maxwell A
EcoSal Plus; 2015; 6(2):. PubMed ID: 26435256
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in bacterial topoisomerase inhibitors.
Bradbury BJ; Pucci MJ
Curr Opin Pharmacol; 2008 Oct; 8(5):574-81. PubMed ID: 18555745
[TBL] [Abstract][Full Text] [Related]
13. Bacterial topoisomerase I as a target for discovery of antibacterial compounds.
Tse-Dinh YC
Nucleic Acids Res; 2009 Feb; 37(3):731-7. PubMed ID: 19042977
[TBL] [Abstract][Full Text] [Related]
14. Novel compounds targeting bacterial DNA topoisomerase/DNA gyrase.
Ehmann DE; Lahiri SD
Curr Opin Pharmacol; 2014 Oct; 18():76-83. PubMed ID: 25271174
[TBL] [Abstract][Full Text] [Related]
15. [Bacterial type II topoisomerases as targets for antibacterial drugs].
Pietrusiński M; Staczek P
Postepy Biochem; 2006; 52(3):271-82. PubMed ID: 17201062
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents.
Nimesh H; Sur S; Sinha D; Yadav P; Anand P; Bajaj P; Virdi JS; Tandon V
J Med Chem; 2014 Jun; 57(12):5238-57. PubMed ID: 24856410
[TBL] [Abstract][Full Text] [Related]
17. Bacterial DNA replication enzymes as targets for antibacterial drug discovery.
Sanyal G; Doig P
Expert Opin Drug Discov; 2012 Apr; 7(4):327-39. PubMed ID: 22458504
[TBL] [Abstract][Full Text] [Related]
18. Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antibacterial activity.
Baumann S; Herrmann J; Raju R; Steinmetz H; Mohr KI; Hüttel S; Harmrolfs K; Stadler M; Müller R
Angew Chem Int Ed Engl; 2014 Dec; 53(52):14605-9. PubMed ID: 25510965
[TBL] [Abstract][Full Text] [Related]
19. Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
Casu L; Cottiglia F; Leonti M; De Logu A; Agus E; Tse-Dinh YC; Lombardo V; Sissi C
Bioorg Med Chem Lett; 2011 Dec; 21(23):7041-4. PubMed ID: 22014547
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II).
Cheng B; Annamalai T; Sandhaus S; Bansod P; Tse-Dinh YC
PLoS One; 2015; 10(3):e0120022. PubMed ID: 25798600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
